Skip to main content
Faculty Featured Featured News News Pharmaceutical Outcomes and Policy Sidebar Featured News,
Mariava Phillips
January 17, 2024



Lisa Spees, Ph.D. ‘16, joins the UNC Eshelman School of Pharmacy as an assistant professor in the Division of Pharmaceutical Outcomes and Policy (DPOP) this month. She holds a dual appointment with the UNC Gillings School of Global Public Health. 

“I’m excited to be contributing my expertise in rural health equity, cost and cost effectiveness analyses, and community-engaged research methods to the phenomenal team of researchers in DPOP,” said Spees. 

She is trained as a health services researcher and decision scientist focused on improving care quality, equity and value for cancer populations. Her research focuses on identifying multi-level barriers across the cancer care continuum using both qualitative and quantitative methods. Spees is especially knowledgeable in handling complex health care claims analyses including the Cancer Information and Population Health Resource (CIPHR), a North Carolina Cancer Registry Data linked to private and public insurance claims data, and Surveillance, Epidemiology and End Results (SEER)-Medicare. Currently, her research focuses specifically on improving rural cancer care through community-engaged research methods and cost-effectiveness analyses. 

“We are very excited to welcome Dr. Spees to the DPOP family,” said Ronny Bell, Ph.D., Fred Eshelman Distinguished Professor and chair of DPOP. “She has already been well engaged with our faculty and students, so she is a natural fit.  She brings a number of talents that align with our mission, and I am sure she will continue her successful professional trajectory.”  

Spees serves as the director of cancer health assets and needs assessment in the Office of Community Outreach and Engagement at the Lineberger Comprehensive Cancer Center. She is also an associate member of the Cancer Prevention and Control Program, and a member of the Culture, Climate and Training committee within the Lineberger Equity Council. 

Latest News


Comments are closed.